KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Operating Leases (2018 - 2025)

Historic Operating Leases for Vertex Pharmaceuticals (VRTX) over the last 8 years, with Q4 2025 value amounting to $1.9 billion.

  • Vertex Pharmaceuticals' Operating Leases rose 1791.6% to $1.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.9 billion, marking a year-over-year increase of 1791.6%. This contributed to the annual value of $1.9 billion for FY2025, which is 1791.6% up from last year.
  • As of Q4 2025, Vertex Pharmaceuticals' Operating Leases stood at $1.9 billion, which was up 1791.6% from $1.8 billion recorded in Q3 2025.
  • Vertex Pharmaceuticals' 5-year Operating Leases high stood at $1.9 billion for Q4 2025, and its period low was $354.4 million during Q3 2023.
  • Its 5-year average for Operating Leases is $779.6 million, with a median of $382.0 million in 2022.
  • As far as peak fluctuations go, Vertex Pharmaceuticals' Operating Leases plummeted by 1083.86% in 2023, and later soared by 36698.65% in 2024.
  • Over the past 5 years, Vertex Pharmaceuticals' Operating Leases (Quarter) stood at $410.7 million in 2021, then rose by 4.24% to $428.1 million in 2022, then dropped by 10.84% to $381.7 million in 2023, then skyrocketed by 327.43% to $1.6 billion in 2024, then grew by 17.92% to $1.9 billion in 2025.
  • Its Operating Leases was $1.9 billion in Q4 2025, compared to $1.8 billion in Q3 2025 and $1.5 billion in Q2 2025.